Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Emerging concepts in erectile preservation following radical prostatectomy: a guide for clinicians

International Journal of Impotence Research volume 23, pages 181–192 (2011)Cite this article

Subjects

Abstract

Radical prostatectomy (RP) is a commonly performed procedure for the management of prostate cancer. While documented oncologic outcome for early stage disease is excellent, functional impairments such as incontinence and erectile dysfunction (ED) are common after the procedure. Recent evidence has implicated cavernous nerve damage and subsequent corporal oxygen deprivation, as well as corporal inflammation, in the pathogenesis of post-RP ED. Targeted therapies such as oral phosphodiesterase-5 inhibitors, mechanical vacuum erection devices, local alprostadil delivery and testosterone replacement (for hypogonal patients) have demonstrated some efficacy in the management of post-RP ED. This review aggregates much of the recent data in support of these therapies and critically reviews them. The article then presents tools to assess patients and partner sexual function to aid in identifying and monitoring post-RP ED. Finally, the article describes a protocol in use at Baylor College of Medicine as a guide toward the development of a protocol for erectile preservation (EP). The purpose of this work is to educate clinicians on emerging concepts in EP and provide an implementable protocol for use in practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66.

    Article  Google Scholar 

  2. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR . The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22: 2141–2149.

    Article  Google Scholar 

  3. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 1672–1694.

    Article  Google Scholar 

  4. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC . Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555–565.

    Article  CAS  Google Scholar 

  5. Althof SE . Quality of life and erectile dysfunction. Urology 2002; 59: 803–810.

    Article  Google Scholar 

  6. Rosen RC . Quality of life assessment in sexual dysfunction trials. Int J Impot Res 1998; 10 (Suppl 2): S21–S23; discussion S24–26.

    PubMed  Google Scholar 

  7. Kaminetsky JC, Depko AJ, Stroberg P, Buvat J, Tseng LJ, Stecher VJ . In men with erectile dysfunction, satisfaction with quality of erections correlates with erection hardness, treatment satisfaction, and emotional well-being. J Sex Med 2009; 6: 800–808.

    Article  Google Scholar 

  8. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E . How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J Sex Med 2008; 5: 448–457.

    Article  Google Scholar 

  9. Teloken P, Mesquita G, Montorsi F, Mulhall J . Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med 2009; 6: 2032–2038.

    Article  Google Scholar 

  10. Burnett AL . Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology 2003; 61: 491–497.

    Article  Google Scholar 

  11. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24: 239–245.

    Article  Google Scholar 

  12. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT . Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175–1179.

    Article  Google Scholar 

  13. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G et al. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158: 626–630.

    Article  CAS  Google Scholar 

  14. Schwartz EJ, Wong P, Graydon RJ . Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171 (2 Part 1): 771–774.

    Article  Google Scholar 

  15. Muller A, Tal R, Donohue JF, Akin-Olugbade Y, Kobylarz K, Paduch D et al. The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. J Sex Med 2008; 5: 562–570.

    Article  CAS  Google Scholar 

  16. Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI et al. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med 2010; 7: 3659–3665.

    Article  Google Scholar 

  17. McCullough AR, Levine LA, Padma-Nathan H . Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008; 5: 476–484.

    Article  CAS  Google Scholar 

  18. Padma-Nathan H MA, Giuliano F, Toler SM, Wohlhuter C, Shpilsky AB . Post-operative nightly administration of sildenafil citrate significantly improves the return of normal sponta-neous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 169 (Suppl): 375–376.

    Google Scholar 

  19. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008; 20: 479–486.

    Article  CAS  Google Scholar 

  20. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP . Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008; 101: 1279–1283.

    Article  CAS  Google Scholar 

  21. Montorsi F, McCullough A . Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005; 2: 658–667.

    Article  CAS  Google Scholar 

  22. Mulhall JP . The role and structure of a postradical prostatectomy penile rehabilitation program. Curr Urol Rep 2009; 10: 219–225.

    Article  Google Scholar 

  23. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54: 924–931.

    Article  CAS  Google Scholar 

  24. Mulhall JP, Muller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA et al. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008; 5: 1126–1136.

    Article  CAS  Google Scholar 

  25. Mulhall JP, Graydon RJ . The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996; 8: 91–94.

    CAS  Google Scholar 

  26. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408–1410.

    Article  CAS  Google Scholar 

  27. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371–1375.

    Article  Google Scholar 

  28. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med 1997; 336: 1–7.

    Article  CAS  Google Scholar 

  29. Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT et al. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol 1998; 160 (6 Part 1): 2041–2046.

    Article  CAS  Google Scholar 

  30. Raina R, Agarwal A, Zaramo CE, Ausmundson S, Mansour D, Zippe CD . Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2005; 17: 86–90.

    Article  CAS  Google Scholar 

  31. McCullough AR, Hellstrom WG, Wang R, Lepor H, Wagner KR, Engel JD . Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol 2010; 183: 2451–2456.

    Article  CAS  Google Scholar 

  32. Magheli A, Burnett AL . Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol 2009; 6: 415–427.

    Article  Google Scholar 

  33. Zippe CD, Raina R, Thukral M, Lakin MM, Klein EA, Agarwal A . Management of erectile dysfunction following radical prostatectomy. Curr Urol Rep 2001; 2: 495–503.

    Article  CAS  Google Scholar 

  34. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 2006; 18: 77–81.

    Article  CAS  Google Scholar 

  35. Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007; 100: 858–862.

    Article  Google Scholar 

  36. Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G . Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol 1995; 75: 786–791.

    Article  CAS  Google Scholar 

  37. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC . The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532–540; discussion 540–532.

    Article  CAS  Google Scholar 

  38. Wang R . Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? J Sex Med 2007; 4 (4 Part 2): 1085–1097.

    Article  Google Scholar 

  39. Marin R, Escrig A, Abreu P, Mas M . Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes. Biol Reprod 1999; 61: 1012–1016.

    Article  CAS  Google Scholar 

  40. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M et al. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol 2005; 47: 409–416; discussion 416.

    Article  CAS  Google Scholar 

  41. Traish AM, Toselli P, Jeong SJ, Kim NN . Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl 2005; 26: 242–248.

    Article  Google Scholar 

  42. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H . Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172: 658–663.

    Article  CAS  Google Scholar 

  43. Armagan A, Kim NN, Goldstein I, Traish AM . Dose-response relationship between testosterone and erectile function: evidence for the existence of a critical threshold. J Androl 2006; 27: 517–526.

    Article  CAS  Google Scholar 

  44. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K . The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med 2007; 4 (4 Part 1): 1056–1069.

    Article  Google Scholar 

  45. Khera M . Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep 2010; 11: 393–399.

    Article  Google Scholar 

  46. Morgentaler A . Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol 2009; 181: 972–979.

    Article  Google Scholar 

  47. Shindel A, Quayle S, Yan Y, Husain A, Naughton C . Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J Sex Med 2005; 2: 833–841; discussion 841.

    Article  Google Scholar 

  48. Conaglen JV, Conaglen HM . The effects of treating male hypogonadism on couples’ sexual desire and function. J Sex Med 2009; 6: 456–463.

    Article  CAS  Google Scholar 

  49. Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P et al. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699–708.

    Article  CAS  Google Scholar 

  50. Descazeaud A, Debre B, Flam TA . Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 2006; 176 (6 Part 1): 2594–2598; discussion 2598.

    Article  Google Scholar 

  51. Swindle RW, Cameron AE, Lockhart DC, Rosen RC . The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav 2004; 33: 19–30.

    Article  Google Scholar 

  52. Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K . Validation of the erection hardness score. J Sex Med 2007; 4: 1626–1634.

    Article  Google Scholar 

  53. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  Google Scholar 

  54. Cappelleri JC, Rosen RC . The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307–319.

    Article  CAS  Google Scholar 

  55. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  Google Scholar 

  56. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191–208.

    Article  CAS  Google Scholar 

  57. Wiegel M, Meston C, Rosen R . The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1–20.

    Article  Google Scholar 

  58. Derogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y . Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008; 5: 357–364.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA

    D J Moskovic, B J Miles, L I Lipshultz & M Khera

  2. Columbia Business School, New York, NY, USA

    D J Moskovic

Authors
  1. D J Moskovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B J Miles
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L I Lipshultz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Khera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Khera.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moskovic, D., Miles, B., Lipshultz, L. et al. Emerging concepts in erectile preservation following radical prostatectomy: a guide for clinicians. Int J Impot Res 23, 181–192 (2011). https://doi.org/10.1038/ijir.2011.26

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2011.26

Keywords

This article is cited by

Search

Advanced search

Quick links